Therini Bio
A biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction.
Launch date
Employees
Market cap
-
Enterprise valuation
€131—196m (Dealroom.co estimates Apr 2023.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Spinout | |
$9.4m | Seed | ||
$17.0m | Seed | ||
* | $36.0m | Series A | |
Total Funding | €56.7m |
Related Content
Recent News about Therini Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.